OBJECTIVES We investigated the effect of dietary zinc supplementation and deficiency in mice consuming a high-fat on cardiac inflammation, cardiac fibrosis, and left ventricular function and structure using an animal model of adolescent obesity.
METHODS Male C57BL/6J mice (3 weeks of age) were fed either high fat diet (HFD, 60% kcal fat) or normal diet (ND, 10% kcal fat) containing low zinc (L-Zn, 10 mg Zn per 4057 kcal), normal zinc (N-Zn, 30 mg Zn per 4057 kcal) or high zinc (H-Zn, 90 mg Zn per 4057 kcal) for 3 or 6 months. Left ventricular function and structure were measured by Echocardiography. TNF-alpha (TNF-a), nuclear factor kappa-B (NF-kB), B-cell CLL/lymphoma 10 (BCL10), caspase recruitment domain (CARD9), and phosphorylated and total MAPK p38 were assessed by western blot. The mRNA expression of connective tissue growth factor (CTGF), transforming growth factor b1 (TGF-b1), and atrial natriuretic peptide (ANP) in the heart were quantified by RT-PCR. The cardiac collagen content was analyzed by Sirius red staining. For myocyte cross-sectional area, sections were stained for membranes with FITC-conjugated WGA (wheat germ agglutintin).
RESULTS
We found that HFD increased the expression of both phosphorylated and total p38 MAPK in the heart, along with the increased heart weight and hypertrophy in a time-dependent manner. Echocardiography demonstrated the cardiac hypertrophy in HFD mice, which was confirmed by WGA staining at cellular level. Although echocardiography and WGA staining revealed signs of cardiac hypertrophy in all obese mice, the increase in left ventricular (LV) mass and diameter was significantly more pronounced in Zn-defect HFD mice, and, the HFD with H-Zn attenuated the hypertrophy. Cardiac inflammatory levels and fibrosis were increased in obese animals compared to mice fed by ND. Cardiac hypertrophy increased level was positive correlation with inflammatory response and fibrosis change. The cardiac structural changes and cellular and molecular hypertrophy was significantly more pronounced in6 months than 3 months. In 3-month time-point, Zn-defect HFD significantly increased the expression of TNF-a, BCL10, CARD9, ANP, CTGF, TGF-b1and NF-kB slightly increased. In contrast, at 6-month time-point, Zndefect HFD significantly elevated levels of NF-kB, p38 MAPK, but only slightly increased TNF-a, BCL10, CARD9, ANP, CTGF, TGF-b1. Znsupplemented HFD reduced the gene activity above. No changed cardiac fibrosis and structure was noticed in ND disregarding Zn levels. HFD with L-Zn increased the BCL10/CARD9, resulted in NF-kB nuclear translocation, and increased p38 MAPK gene activity. Inhibition of p38MAPK reduced the cardiac hypertrophy induced by HFD with Zn deficiency.
CONCLUSIONS Obesity with zinc deficiency elevated p38MAPK gene expression via BCL10/CARD9/NF-kB pathway, and its effect is blocked by zinc supplementation, demonstrating the potential.
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Late sodium current plays a role in proarrhythmic and antiarrhythmic effects of QT prolonging drugs of multichannel blocking properties Lu Ren, Lin Wu Peking University First Hospital OBJECTIVES Proarrhythmic and antiarrhythmic effects of QT prolonging drugs vary significantly. The purpose of this study was to examine the role of late sodium current as a modulator of proarrhythmic and antiarrhythmic effects of multichannel blocking drugs.
METHODS New-Zealand White rabbit hearts were isolated and perfused in Langendorff mode. Hearts were paced at a rate of 1 Hz after themo-ablation of AV node. Monophasic action potential duration (MAPD) from the epicardium and ECG signals were recorded in normal hearts and in hearts pretreated with a late I Na enhancer ATX-II before and after the exposure of increasing concentrations of dronedarone (1 nM-10 mM), amiodarone (1 nM-10 mM) and ranolazine (0.1-100 mM) in a cumulative manner.
RESULTS ATX-II (1-3 nM) alone prolonged LV MAPD 90 by 189AE3, 255AE17, and 328AE23 ms (n ¼5, P < 0.05) from control of 171AE3 ms. Dron alone and Ran alone caused concentration-dependent "monotonic" prolongations of MAPD 90 by up to 6AE1 ms and 60 AE 4 ms (n¼8, P < 0.05), causing no arrhythmias. Amio alone prolonged MAPD 90 by 2AE2 ms at the concentration of 30 nM and shortened MAPD 90 by 13AE6ms (n ¼10, P < 0.05) at the concentration of 10 mM, without causing any arrhythmias. However, in the presence of 3 nM ATX-II, a stepwise increase in the concentrations of Amio and Dron were associated with a biphasic response, initially inducing arrhythmic activity and then suppressing it. Dron and Amio significantly increased MAPD 90 by 35AE3 ms (n ¼4, P < 0.05) and 41AE2 ms (n¼12, P < 0.05) at the concentration of 300 nM and 30 nM, but decreased MAPD 90 by 12AE10 ms (n ¼4, P < 0.05) and 73AE4 ms (n ¼12, P < 0.05) at the concentration of 10 mM, respectively. When hearts were pretreated with 1 nM ATX-II, the prolongation of MAPD 90 by Ran was only 43 AE 14 ms (n ¼6, P < 0.05), and when hearts were pretreated with 3 nM ATX-II, MAPD 90 was decreased by up to 107AE10 ms (n ¼11, P < 0.05), no arrhythmias observed.
CONCLUSIONS When late I Na is augmented, amiodarone and dronedarone have concentration -dependent biphasic effects to induce and then suppress arrhythmic activity owing to their proarrhythmic window, but ranolazine had no proarrhythmic window so that it caused no proarrhythmic activities.
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Role of NRG-1 released from cardiac microvascular endothelial cells in ischemia/reperfusion myocardium and its mechanism of action Qimeng Hao, Wenyi Guo Xijing hospital OBJECTIVES To explore the effects of NRG-1 that released from CMECs on cardiomyocytes during ischemia/reperfusion injury and discuss the possible mechanism.
METHODS Cardiac myocytes were isolated from the hearts of neonatal rats and CMECs from the adult rats. CMECs -cardiomyocytes coculture model was established. Then cells were endured simulated I/R (4 h/4 h). Collected CMECs culture medium during SI/R. CMECs were randomly divided into two groups: Control group, SI/R group(ischemia 2, 4, 6h, reperfusion 4h). While cardiomyocytes were randomly divided into following groups: Control group, SI/R group, SI/R þ Coculture group, SI/R þ Coculture þ anti-ErbB2 (ErbB2 inhibitor) group, SI/R þ NRG-1 group, SI/R þ NRG-1 þ anti-ErbB2 group, SI/R þ NRG-1 þ PD group. The cell viability of cardiomyocytes was measured by MTT assay. The apoptosis of cardiomyocytes was detected by TUNEL method. The expression of secreted NRG-1 in CMECs culture medium, phosphorylation of ErbB2 and ERK and COX-2 in cardiac myocytes were analyzed by Western blot. Measured caspase-3 activity reflected the apoptosis of cardiomyocytes.
RESULTS
The cardiomyocytes viability was impaired in the SI/R (4h/4h) group (P < 0.01 vs. Control) while increased in the SI/ RþCoculture group (P < 0.05 vs. SI/R). Within the groups of CMECs, the secretion of NRG-1 was remarkable increased in the time of 4h/ 4h under SI/R (P < 0.01) when compared with the Control group. Within the groups of cardiomyocytes, the apoptosis index and Caspase-3 activity were increased after SI/R (27.97 AE 0.90 vs. 3.58 AE 0.23, P < 0.01; 375.93 AE 11.76 vs. 100.00 AE 0.00, P < 0.01). While trained with Coculture or NRG-1 during SI/R could reduce the apoptosis index and Caspase-3 activity (16.82 AE 1.03 vs. 27.97 AE 0.90, P < 0.01; 166.16 AE 15.15 vs. 375.93 AE 11.76, P < 0.01). Besides, they can significant up-regulate the level of phosphorylation of ErbB2 and ERK and the expression of COX-2 (P < 0.01 vs. Control and SI/R). However, when cardiomyocytes were pretreated with ErbB2 or ERK1/2 inhibitor, the effect of Coculture and NRG-1 vanished (P < 0.01).
CONCLUSIONS In the process of I/RI, the secretion of NRG-1 in CMECs protect cardiomyocytes against ischemic reperfusion injury through up-regulation of pErbB2 and activation of downstream ERK/COX-2 signal.
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